Diseases » Age-related macular degeneration » Clinical Trials

Clinical Trials for Age-related macular degeneration

Clinical trials are research studies conducted in an effort to improve overall patient health and care. Each trial involves running supervised tests to determine the effectiveness and safety of new drugs, procedures and/or devices with the aim of answering scientific questions about a disease or condition. Risks and side-effects are also evaluated during these trials with results ranging from being unpleasant, with side effects such as headaches, to more serious or even life-threatening risks. A clinical trial may be separated into phases, or steps, with each step designed to answer a separate research question. This maybe reflected in the trial name.

A brief description of each phase:

Phase I: Usually designed to evaluate safety, determine a safe dosage range, and identify side effects on a small group of patients.
Phase II: If Phase I is successful, the trial is then repeated with a larger group to further evaluate its effect and safety.
Phase III: Trials are conducted on an ever larger group and are compared with the best current treatment while gathering more information on effect and safety.
Phase IV: These studies monitor long-term side effects after the treatment has been marketed.

Clinical Trials data for Age-related macular degeneration is grouped into the following categories:-

View by trial name

View by drugs used in Age-related macular degeneration clinical trials

Clinical Trials by trial name

The format for each of the following is:

The name of the trial,
followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.
followed by a list of drug/s, if any, used in the trial

ClinicalTrials.gov has listed the following trials for Age-related macular degeneration:

Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic Therapy - This study has been completed (Current: 23 Nov 2006) - Celecoxib
Identification and Treatment of Feeder Vessels in Macular Degeneration - This study is no longer recruiting patients (Current: 23 Nov 2006)
Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD) - This study is currently recruiting patients (Current: 23 Nov 2006) - Photodynamic Therapy (PDT) with Visudyne (verteporfin),Macugen (pegaptanib sodium)
Study To Determine Safety/Efficacy of Lucentis For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular Degeneration - This study is currently recruiting patients (Current: 23 Nov 2006) - Lucentis,Ranibizumab
Screening for Studies on Retinovascular Diseases - This study is currently recruiting patients (Current: 23 Nov 2006)
An Evaluation of Safety and Efficacy of Anecortave Acetate Vs. Placebo in Patients With Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD) - This study is currently recruiting patients (Current: 23 Nov 2006) - anecortave acetate
An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD - This study is no longer recruiting patients (Current: 23 Nov 2006) - anecortave acetate
A Clinical Trial to Explore the Safety and Efficacy of Three Different Doses of Pegaptanib Sodium in Patients With Wet Age-Related Macular Degeneration (AMD) - This study is currently recruiting patients (Current: 23 Nov 2006) - Pegaptanib sodium
Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration - This study is currently recruiting patients (Current: 23 Nov 2006) - Triamcinolone Acetonide,TAC-PF
Fluocinolone Implant to Treat Macular Degeneration - This study has been completed (Current: 23 Nov 2006) - Fluocinolone
Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration - This study is currently recruiting patients (Current: 23 Nov 2006) - Daclizumab
Phase 3 Study to Evaluate Anecortave Acetate Vs. Visudyne for the Treatment of the Wet Form of AMD. - This study is no longer recruiting patients (Current: 23 Nov 2006) - Anecortave Acetate
Open-Label Posterior Juxtascleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients With AMD - This study is currently recruiting patients (Current: 23 Nov 2006) - Anecortave Acetate
Intravitreal v. Sub-Tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders - This study is currently recruiting patients (Current: 23 Nov 2006) - Triamcinolone Acetonide
Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD) - This study has been completed (Current: 23 Nov 2006) - Macugen ™ (pegaptanib sodium injection)
Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD) - This study has been completed (Current: 23 Nov 2006) - pegaptanib sodium
A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD. - This study has been completed (Current: 23 Nov 2006) - Pegaptanib sodium
Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System - This study is currently recruiting patients (Current: 23 Nov 2006)
Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration - This study is currently recruiting patients (Current: 23 Nov 2006) - Photrex (rostaporfin)
Novel Diagnostics With Optical Coherence Tomography: Retinal Imaging - This study is currently recruiting patients (Current: 23 Nov 2006)
Long-Term Efficacy in AMD of Rheopheresis in North America - This study is no longer recruiting patients (Current: 23 Nov 2006)
Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders - This study is no longer recruiting patients (Current: 23 Nov 2006) - Triamcinolone Acetonide (TAC-PF)
Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60 - This study is currently recruiting patients (Current: 23 Nov 2006) - Lutein
Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate - This study is currently recruiting patients (Current: 23 Nov 2006) - Anecortave Acetate
Age-Related Eye Disease Study (AREDS) - This study is no longer recruiting patients (Current: 23 Nov 2006) - Antioxidants,Zinc
Randomized Trial of Beta-Carotene and Macular Degeneration - This study is no longer recruiting patients (Current: 23 Nov 2006) - Aspirin,Beta-Carotene
Randomized Trials of Vitamin Supplements and Eye Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - Aspirin,Beta-Carotene,Vitamin C,Vitamin E
Complications of Age-Related Macular Degeneration Prevention Trial (CAPT) - This study is no longer recruiting patients (Current: 23 Nov 2006)
Age-Related Macular Degeneration and Cataract - This study is no longer recruiting patients (Current: 23 Nov 2006) - Vitamin and/or Mineral Supplement
Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration - This study has been completed (Current: 23 Nov 2006)
Lutein for Age-Related Macular Degeneration - This study has been completed (Current: 23 Nov 2006) - Lutein
A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration - This study is no longer recruiting patients (Current: 23 Nov 2006) - Retisert Implant
Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD) - This study is no longer recruiting patients (Current: 23 Nov 2006)
A Study of rhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD) - This study is no longer recruiting patients (Current: 23 Nov 2006) - rhuFab V2 (ranibizumab)
Metabolic Mapping to Measure Retinal Metabolism - This study is currently recruiting patients (Current: 23 Nov 2006)
A Study to Evaluate rhuFab V2 in Subjects With Minimally Classic or Occult Subfoveal Neovascular Macular Degeneration - This study has been completed (Current: 23 Nov 2006) - rhuFab V2 (ranibizumab)
A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration - This study has been completed (Current: 23 Nov 2006) - rhuFab V2 (ranibizumab)
Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD) - This study is no longer recruiting patients (Current: 23 Nov 2006) - rhuFab V2 (ranibizumab)
Study of AdGVPEDF.11D in Neovascular Age-Related Macular Degeneration (AMD) - This study has been completed (Current: 23 Nov 2006) - AdGVPEDF.11D
Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Wet Age-Related Macular Degeneration - This study is no longer recruiting patients (Current: 23 Nov 2006) - Cand5
Safety and Tolerability of Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Neovascular Age-Related Macular Degeneration (AMD) - This study is currently recruiting patients (Current: 23 Nov 2006) - VEGF Trap
Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD) - This study is currently recruiting patients (Current: 23 Nov 2006) - VEGF Trap
Visudyne in Occult (VIO) - This study has been completed (Current: 23 Nov 2006) - Visudyne for injection
Genetic Factors in Age-Related Macular Degeneration - This study is currently recruiting patients (Current: 23 Nov 2006)
MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With "Wet" Age-Related Macular Degeneration (AMD) - This study has been completed (Current: 23 Nov 2006) - MSI-1256F (Squalamine Lactate)
Intravitreal Bevacizumab for Age-Related Macular Degeneration - This study is currently recruiting patients (Current: 23 Nov 2006) - bevacizumab intravitreal injection
Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration - This study is currently recruiting patients (Current: 23 Nov 2006) - bevacizumab intravitreal injection
Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Monotherapy - Intravitreal Ranibizumab Alone for the Treatment of Age-Related Macular Degeneration. - This study is currently recruiting patients (Current: 23 Nov 2006) - Visudyne Photodynamic therapy,intravitreal Dexamethasone,Lucentis
Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD. - This study is currently recruiting patients (Current: 23 Nov 2006) - Triamcinolone Acetonide
Investigating Age-Related Macular Degeneration - This study is currently recruiting patients (Current: 23 Nov 2006)
High-Resolution Ultrasound Imaging of the Retina and Choroid for Detection on Age Related Macular Degeneration - This study is currently recruiting patients (Current: 23 Nov 2006)
Combination Therapy for Age-Related Macular Degeneration. - This study is currently recruiting patients (Current: 23 Nov 2006) - Avastin (Bevacizumab)
Study of the Safety, Tolerability and Pharmacokinetics of 1 Mg/Eye and 3 Mg/Eye Pegaptanib Sodium in Patients With Exudative Age-Related Macular Degeneration (AMD) - This study has been completed (Current: 23 Nov 2006) - pegaptanib sodium (Macugen)
Ultrasonic Evaluation of Ocular Tissues - This study is currently recruiting patients (Current: 23 Nov 2006)
Neovascular Age Related Macular Degeneration (AMD), Periocular Corticosteroids, and Photodynamic Therapy (PDT) - This study has been completed (Current: 23 Nov 2006) - Periocular injection of triamcinolone acetonide 40mg
OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration - This study is currently recruiting patients (Current: 23 Nov 2006) - OT - 551
Detection of Topographic Residual Acuity in Patients With Age Related Macular Degeneration - This study is currently recruiting patients (Current: 23 Nov 2006)
Age-Related Eye Disease Study 2 (AREDS2) - This study is currently recruiting patients (Current: 23 Nov 2006) - lutein,zeaxanthin,docosahexaenoic acid,eicosapentaenoic acid
Genetic Study of Age-Related Macular Degeneration - This study is currently recruiting patients (Current: 23 Nov 2006)
The Avastin vs Visudyne for Neovascular AMD Study - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Bevacizumab (Avastin),Verteporfin photodynamic therapy (PDT)
EXCITE - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (ARMD) - This study is currently recruiting patients (Current: 23 Nov 2006) - Ranibizumab
Fundus Autofluorescence Imaging in Age-Related Macular Degeneration Using Confocal Scanning Laser Ophthalmoscopy - This study is currently recruiting patients (Current: 23 Nov 2006)
A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD - This study is currently recruiting patients (Current: 23 Nov 2006) - pegaptanib sodium (Macugen)
Submacular Surgery Trials (SST) - This study is no longer recruiting patients (Current: 23 Nov 2006)
Branch Vein Occlusion Study - This study has been completed (Current: 23 Nov 2006)
Macular Photocoagulation Study (MPS) - This study is no longer recruiting patients (Current: 23 Nov 2006)
Diabetic Retinopathy and Visual Function Study - This study has been completed (Current: 23 Nov 2006)
Long Term Follow-Up of Diabetic Retinopathy - This study has been completed (Current: 23 Nov 2006)
Phase II/III Study of Anti-VEGF in Neovascular AMD - This study has been completed (Current: 23 Nov 2006) - EYE001 anti-VEGF aptamer
Multi-Ethnic Study of Atherosclerosis (MESA) - Ancillary Eye Study - This study is no longer recruiting patients (Current: 23 Nov 2006)
Preventing Depression in Patients With Macular Degeneration - This study is currently recruiting patients (Current: 23 Nov 2006)
Laser and Medical Treatment of Diabetic Macular Edema - This study is no longer recruiting patients (Current: 23 Nov 2006) - celecoxib (Celebrex)
Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-Like Macular Dystrophy - This study is currently recruiting patients (Current: 23 Nov 2006) - Docosahexaenoic Acid (DHA) Dietary Supplement
A Safety and Efficacy Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration - This study has been completed (Current: 23 Nov 2006) - MSI-1256F (Squalamine Lactate)
A Study Of The Safety And Efficacy Of An Investigational Drug In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration - This study is currently recruiting patients (Current: 23 Nov 2006) - Investigational New Drug
Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease - This study has been terminated (Current: 23 Nov 2006) - Talaporfin Sodium (LS11) Photodynamic Therapy (PDT)
Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration) - This study is currently recruiting patients (Current: 23 Nov 2006) - pegaptanib sodium
Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration - This study has been completed (Current: 23 Nov 2006) - Immune Globulin Intravenous (Human)
Clinical Study Of EYE001 For Wet-Type Age-Related Macular Degeneration - This study is currently recruiting patients (Current: 23 Nov 2006) - pegaptanib sodium
Retinal Imaging in Patients With Inherited Retinal Degenerations - This study is currently recruiting patients (Current: 23 Nov 2006)
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion - This study is currently recruiting patients (Current: 23 Nov 2006) - dexamethasone
Evaluation Of Safety And Efficacy Of 0.3 Mg/Eye Macugen In Patients With Small Age-Related Macular Degeneration Lesions - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - pegaptanib sodium (Macugen)
An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD. - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Pegaptanib Sodium 0.3 mg
A Safety and Efficacy Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration - This study is currently recruiting patients (Current: 23 Nov 2006) - MSI-1256F (Squalamine Lactate)
Tracking Optical Coherence Tomography - This study is currently recruiting patients (Current: 23 Nov 2006)
Phase II Pilot Study of Visudyne Photodynamic Therapy (PDT) (Low and Very Low Fluence) Combined With Bevacizumab. - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - verteporfin (Visudyne) in combination with bevacizumab
An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD - This study is no longer recruiting patients (Current: 23 Nov 2006) - Lucentis (ranibizumab)
PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization - This study is currently recruiting patients (Current: 23 Nov 2006)
PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV) - This study is currently recruiting patients (Current: 23 Nov 2006)
Photodynamic Therapy in Occult-Only Lesions (POOL) - This study has been completed (Current: 23 Nov 2006) - Verteporfin for injection
Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular Degeneration - This study is currently recruiting patients (Current: 23 Nov 2006) - Visudyne,Kenalog
Treatment of Age-Related Macular Degeneration With Open-Label Anecortave Acetate Sterile Suspension (15mg.) Following Failed Treatment With Photodynamic Therapy With Visudyne. - This study is no longer recruiting patients (Current: 23 Nov 2006) - Anecortave Acetate Sterile Suspension ( 15mg.)
A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) - This study is currently recruiting patients (Current: 23 Nov 2006) - rhuFab V2 (ranibizumab)
PDT Study for Exudative AMD With PCV - This study is currently recruiting patients (Current: 23 Nov 2006)
PDT Vs TTT in Occult CNV in AMD - This study is no longer recruiting patients (Current: 23 Nov 2006)
Prophylactic Laser Treatment of Drusen Maculopathy - This study is currently recruiting patients (Current: 23 Nov 2006)
A Study Using Intravitreal Injections of a Small Interfering RNA in Patients With Age-Related Macular Degeneration - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - AGN211745
Transplantation of Autologous RPE Versus Translocation of Autologous RPE and Choroid in AMD - This study is currently recruiting patients (Current: 23 Nov 2006)
Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular Degeneration - This study is no longer recruiting patients (Current: 23 Nov 2006) - ranibizumab
Anecortave Acetate 15 Mg Administered Every 3 Months Versus Anecortave Acetate 15 Mg Administered Every 6 Months Versus Anecortave Acetate 30 Mg Administered Every 6 Months in Patients With Exudative AMD - This study is currently recruiting patients (Current: 23 Nov 2006) - Anecortave Acetate
SUSTAIN Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration - This study is currently recruiting patients (Current: 23 Nov 2006) - ranibizumab
PHASE I SINGLE DOSE TRIAL OF Sirna-027 IN PATIENT WITH AMD - This study has been completed (Current: 23 Nov 2006) - Sirna-027
A Phase II Study of Implants of Encapsulated Human NTC-201 Cells Releasing Ciliary Neurotrophic Factor (CNTF) in Participants With Visual Acuity Impairment Associated With Atrophic Macular Degeneration - This study is currently recruiting patients (Current: 23 Nov 2006)
A Safety and Efficacy Study of Squalamine Lactate for Injection (MSI-1256F) for "Wet" Age-Related Macular Degeneration - This study is currently recruiting patients (Current: 23 Nov 2006) - Squalamine Lactate
Prospective OCT Study With Lucentis for Neovascular AMD (PrONTO Study) - This study has been completed (Current: 23 Nov 2006) - Lucentis (Ranibizumab)
Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD - This study is no longer recruiting patients (Current: 23 Nov 2006) - bevacizumab, triamcinolone acetonide
An OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of Neovascular AMD - This study has been completed (Current: 23 Nov 2006) - Ranibizumab (Lucentis)
Combined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMD - This study is currently recruiting patients (Current: 23 Nov 2006) - verteporfin, bevacizumab, triamcinolone acetonide
Safety Study in Retinal Transplantation for Dry Age Related Macular Degeneration. - This study is currently recruiting patients (Current: 23 Nov 2006)
VERITAS: A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib - This study is no longer recruiting patients (Current: 23 Nov 2006) - intravenous verteporfin, plus intravitreal (intraocular) injection of drug of either triamcinolone acetonide or pegaptanib sodium
Treatment of Patients With Neovascular AMD Using Indocyanine Green-Mediated Photothrombosis (i-MP). - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
To Assess the Safety and Tolerability of Repeated Intravitreal Administration of VEGF Trap in Subjects With Wet AMD - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - VEGF Trap
Pilot Study of the Combination of Anecortave Acetate 15mg Delivered by Posterior Juxtascleral Injection and Triamcinolone Acetonide 4mg Delivered by Intravitreal Injection for the Treatment of Exudative Age-Related Macular Degeneration (AMD) - This study is no longer recruiting patients (Current: 23 Nov 2006) - Anercortave Acetate 15 mg,Triamcinolone Acetate 4mg
Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration - This study is currently recruiting patients (Current: 23 Nov 2006) - Ranibizumab
Randomized Trial of Acetazolamide for Uveitis-Associated Cystoid Macular Edema - This study has been completed (Current: 23 Nov 2006) - Acetazolamide
Vascular Endothelial Growth Factor (VEGF) in Uveitis - This study has been completed (Current: 23 Nov 2006)
Vitamin E to Treat Uveitis-Associated Macular Edema - This study has been completed (Current: 23 Nov 2006) - Vitamin E
Intravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degeneration (AMD) - This study is no longer recruiting patients (Current: 23 Nov 2006) - rhuFab V2 (ranibizumab)
The Standard Care Vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study - This study is currently recruiting patients (Current: 23 Nov 2006) - intravitreal triamcinolone injection
Steroid Injections Vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel Blockage - This study has been completed (Current: 23 Nov 2006) - Triamcinolone Acetonide
Study to Treat Uveitis Associated Macular Edema - This study is no longer recruiting patients (Current: 23 Nov 2006) - denufosol tetrasodium (INS37217) Intravitreal Injection
Measuring Reading Rehabilitation Outcomes - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema - This study is no longer recruiting patients (Current: 23 Nov 2006) - denufosol tetrasodium (INS37217) Intravitreal Injection
ADVANCE: Study of Vatalanib and Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration - This study is currently recruiting patients (Current: 23 Nov 2006) - Vatalanib
Anecortave Acetate Risk Reduction Trial (AART) - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Anecortave Acetate
Anecortave Acetate Risk-Reduction Trial (AART) - This study is currently recruiting patients (Current: 23 Nov 2006) - anecortave acetate
Effect of Prophylactic Ketorolac on CME After Cataract Surgery - This study is currently recruiting patients (Current: 23 Nov 2006) - ketorolac tromethamine 0.5% (Acular®)
Anecortave Acetate Versus Placebo in AMD Patients Following PDT - This study has been completed (Current: 23 Nov 2006) - anecortave acetate
A Phase II Study of Anecortave Acetate for the Treatment of Exudative Age-Related Macular Degeneration - This study has been completed (Current: 23 Nov 2006) - anecortave acetate
Macugen to Prevent Worsening of Macular Edema Following Cataract Surgery in Diabetics - This study is currently recruiting patients (Current: 23 Nov 2006) - Pegaptanib Sodium (Macugen)
The Effect of Macugen in Patients With Chronic, Post-Operative Cystoid Macular Edema - This study is currently recruiting patients (Current: 23 Nov 2006) - Pegaptanib Sodium (Macugen)
Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions Do Not Meet Acceptable Criteria for Standard Care. - This study is no longer recruiting patients (Current: 23 Nov 2006) - Anecortave Acetate
Clinical and Genetic Studies of X-Linked Juvenile Retinoschisis - This study is currently recruiting patients (Current: 23 Nov 2006)
Evaluation and Treatment of Patients With Retinal Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - Standard of care treatment
Novel Diagnostics for Ocular Structure - This study is currently recruiting patients (Current: 23 Nov 2006)
Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration. - This study is currently recruiting patients (Current: 23 Nov 2006) - ranibizumab

Drugs used in Clinical Trials for Age-related macular degeneration

The format for each of the following is:

The drug,
followed by the name of the trial,
followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.

ClinicalTrials.gov has listed the following drugs in trials for Age-related macular degeneration: